中药单体有效成分治疗肥胖的研究进展
Research Progress on the Treatment of Obesity with Active Ingredients of Traditional Chinese Medicine Monomers
DOI: 10.12677/jcpm.2025.46482, PDF,   
作者: 王文娇：黑龙江中医药大学第一临床医学院，黑龙江 哈尔滨；马 建*：黑龙江中医药大学附属第一医院内分泌科，黑龙江 哈尔滨
关键词: 中药单体有效成分；肥胖；山楂；黄芪；丹参；荷叶；Active Ingredients of Traditional Chinese Medicine Monomers； Obesity； Hawthorn； Huangqi； Danshen； Lotus Leaf
摘要: 肥胖是由于体内脂肪细胞的体积和(或)数目的增加导致体质量增长，或体脂占体质量百分比异常增高，局部脂肪沉积过多而引起的疾病。目前肥胖已经成为全球较为严重的公共卫生问题，不仅可能会引起其他并发症，也会给患者带来心理负担，且普通的西药治疗存在诸多弊端，因此挖掘开发相关中药具有十分重要的意义。本文将对中医和西医在肥胖问题上的观点进行阐述，并特别聚焦于中药如山楂、黄芪、荷叶和丹参的有效成分在肥胖治疗方面的最新研究进展，以期为未来临床新药的研发提供全新的方向。
Abstract: Obesity is a disease caused by an increase in the volume and/or number of fat cells in the body, leading to an increase in body mass, or an abnormal increase in the percentage of body fat to body mass, resulting in excessive local fat deposition. At present, obesity has become a serious public health problem worldwide, which may not only cause other complications, but also bring psychological burden to patients. In addition, ordinary Western medicine treatment has many drawbacks, so it is of great significance to explore and develop related traditional Chinese medicine. This article will elaborate on the perspectives of traditional Chinese medicine and Western medicine on obesity, with a particular focus on the latest research progress of effective ingredients in traditional Chinese medicine, such as hawthorn, astragalus, lotus leaves, and Danshen, in the treatment of obesity, in order to provide a new direction for the development of new clinical drugs in the future.
文章引用：王文娇, 马建. 中药单体有效成分治疗肥胖的研究进展[J]. 临床个性化医学, 2025, 4(6): 91-97. https://doi.org/10.12677/jcpm.2025.46482

参考文献

[1] 张娴. 基于MAPK信号通路探讨丹参和四物汤“抗肥胖”的作用机制[D]: [硕士学位论文]. 南昌: 江西中医药大学, 2023.
[2] 周颖, 滕井泉, 田乐乐, 等. 丹参及有效化学成分干预肥胖机制的研究进展[J]. 中药材, 2023, 46(11): 2890-2894.
[3] 中国居民营养与慢性病状况报告(2020年) [J]. 营养学报, 2020, 42(6): 521.
[4] 刘雅星, 周静. 经方治疗肥胖的研究进展[J]. 实用中医内科杂志, 2024, 38(11): 81-84.
[5] 张泓雨, 苑滋潭, 朱杰, 等. 中医治疗单纯性肥胖的临床研究进展[J]. 中国民间疗法, 2022, 30(21): 117-121.
[6] 周坤. 山楂果叶多糖提取物对肥胖小鼠糖脂代谢的作用研究[D]: [硕士学位论文]. 西安: 西北大学, 2022.
[7] 朱文阁, 宋鸽, 周其姝, 等. 有氧运动对高脂饮食饲养的大鼠白色脂肪组织自噬的影响[J]. 中国化学与分子生物学报, 2021, 37(12): 1658-1666.
[8] 牛昶淼, 燕小宁, 殷永凯, 等. 单纯性肥胖的炎症发生机制及中西医治疗进展[J]. 中国中西医结合儿科学, 2024, 16(5): 404-409.
[9] 朱露露, 兰蕾. 关于肥胖的中医药代谢组学研究进展[J]. 中医临床研究, 2023, 15(15): 133-137.
[10] 拓文娟, 刘永琦, 修明慧, 等. 山楂及其有效成分治疗代谢综合征的研究[J]. 中国中医基础医学杂志, 2022, 28(5): 831-838.
[11] 舒丽梅, 王姝雯, 白旭峰, 等. 山楂叶黄酮类成分药理作用及机制研究进展[J]. 中药材, 2024, 47(12): 3192-3199.
[12] 姚子晴, 沈长虹, 张若琪. 牡荆素抗肥胖作用研究及其作用机制初探[J]. 中药与临床, 2024, 15(3): 68-74, 92.
[13] 张祺嘉钰, 赵佩媛, 孙静, 等. 山楂的化学成分及药理作用研究进展[J]. 西北药学杂志, 2021, 36(3): 521-523.
[14] 俞月, 路娟, 吕欣锴, 等. 荷叶碱药理作用及机制研究进展[J]. 中国现代中药, 2021, 23(1): 164-170.
[15] 熊万涛, 廖加抱, 杨智霞, 等. 荷叶碱对肥胖模型小鼠肠道菌群及慢性炎症的影响[J]. 中国中药杂志, 2021, 46(8): 2104-2111.
[16] Gilani, S., Howarth, G.S., Nattrass, G., Kitessa, S.M., Barekatain, R., Forder, R.E.A., et al. (2017) Gene Expression and Morphological Changes in the Intestinal Mucosa Associated with Increased Permeability Induced by Short‐Term Fasting in Chickens. Journal of Animal Physiology and Animal Nutrition, 102, e653. [Google Scholar] [CrossRef] [PubMed]
[17] Vernochet, C., Peres, S.B., Davis, K.E., McDonald, M.E., Qiang, L., Wang, H., et al. (2009) C/EBPα and the Corepressors CtBP1 and CtBP2 Regulate Repression of Select Visceral White Adipose Genes during Induction of the Brown Phenotype in White Adipocytes by Peroxisome Proliferator-Activated Receptor γ Agonists. Molecular and Cellular Biology, 29, 4714-4728. [Google Scholar] [CrossRef] [PubMed]
[18] 李毛毛, 黄鑫源, 梁乾坤, 等. 荷叶水提物对实验性肥胖大鼠脂代谢的影响及机制[J]. 中国应用生理学杂志, 2017, 33(5): 476-480.
[19] 屈媛, 王婷, 付慧婕, 等. 丹参有效成分及药理作用研究进展[J]. 辽宁中医药大学学报, 2024, 26(9): 172-176.
[20] Lin, Z., Bao, Y., Hong, B., Wang, Y., Zhang, X. and Wu, Y. (2021) Salvianolic Acid B Attenuated Cisplatin-Induced Cardiac Injury and Oxidative Stress via Modulating Nrf2 Signal Pathway. The Journal of Toxicological Sciences, 46, 199-207. [Google Scholar] [CrossRef] [PubMed]
[21] 艾梓黎. 基于减重降脂探析“一味丹参, 功同四物”的分子机制[D]: [博士学位论文]. 南昌: 江西中医药大学, 2023.
[22] Jung, D.Y., Kim, J. and Jung, M.H. (2020) Anti-Obesity Effects of Tanshinone I from Salvia Miltiorrhiza Bunge in Mice Fed a High-Fat Diet through Inhibition of Early Adipogenesis. Nutrients, 12, Article 1242. [Google Scholar] [CrossRef] [PubMed]
[23] 李萍, 张瑞航, 锁梦涵, 等. 中药单体激活棕色脂肪组织治疗肥胖研究进展[J]. 中国中西医结合杂志, 2024, 44(6): 752-757.
[24] Zhou, P., Xie, W., He, S., Sun, Y., Meng, X., Sun, G., et al. (2019) Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis. Cells, 8, Article 204. [Google Scholar] [CrossRef] [PubMed]
[25] Wu, Y., Yu, Y., Szabo, A., Han, M. and Huang, X. (2014) Central Inflammation and Leptin Resistance Are Attenuated by Ginsenoside Rb1 Treatment in Obese Mice Fed a High-Fat Diet. PLOS ONE, 9, e92618. [Google Scholar] [CrossRef] [PubMed]
[26] Dai, S., Hong, Y., Xu, J., Lin, Y., Si, Q. and Gu, X. (2018) Ginsenoside Rb2 Promotes Glucose Metabolism and Attenuates Fat Accumulation via AKT-Dependent Mechanisms. Biomedicine & Pharmacotherapy, 100, 93-100. [Google Scholar] [CrossRef] [PubMed]
[27] Kim, K., Nam, K.H., Yi, S.A., Park, J.W., Han, J. and Lee, J. (2020) Ginsenoside Rg3 Induces Browning of 3T3-L1 Adipocytes by Activating AMPK Signaling. Nutrients, 12, Article 427. [Google Scholar] [CrossRef] [PubMed]
[28] 叶紫梦玮, 徐冰蕊, 赵祎, 等. 人参皂苷Rb1、小檗碱及其联合应用对肥胖小鼠肠道菌群的影响[J]. 北京中医药大学学报, 2023, 46(11): 1541-1553.
[29] Li, Z., Xu, J., Zheng, P., et al. (2018) Hawthorn Leaf Flavonoids Alleviate Nonalcoholic Fatty Liver Disease by Enhancing the Adiponectin/AMPK Pathway. Drug Research, 68, 17295-17307.
[30] Richard, A.J. and Stephens, J.M. (2014) The Role of JAK-STAT Signaling in Adipose Tissue Function. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1842, 431-439. [Google Scholar] [CrossRef] [PubMed]
[31] Park, D. and Yoon, M. (2012) Compound K, a Novel Ginsenoside Metabolite, Inhibits Adipocyte Differentiation in 3T3-L1 Cells: Involvement of Angiogenesis and MMPs. Biochemical and Biophysical Research Communications, 422, 263-267. [Google Scholar] [CrossRef] [PubMed]